Allogene Therapeutics Stock Forecast - Accumulation Distribution
| ALLO Stock | USD 1.53 0.02 1.32% |
Allogene Stock outlook is based on your current time horizon. Although Allogene Therapeutics' naive historical forecasting may sometimes provide an important future outlook for the firm, we recommend always cross-verifying it against solid analysis of Allogene Therapeutics' systematic risk associated with finding meaningful patterns of Allogene Therapeutics fundamentals over time.
As of today, The RSI of Allogene Therapeutics' share price is at 52. This suggests that the stock is in nutural position, most likellhy at or near its resistance level. The main idea of RSI analysis is to track how fast people are buying or selling Allogene Therapeutics, making its price go up or down. Momentum 52
Impartial
Oversold | Overbought |
EPS Estimate Next Quarter (0.22) | EPS Estimate Current Year (0.92) | EPS Estimate Next Year (0.89) | Wall Street Target Price 7.3833 | EPS Estimate Current Quarter (0.23) |
Using Allogene Therapeutics hype-based prediction, you can estimate the value of Allogene Therapeutics from the perspective of Allogene Therapeutics response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Allogene Therapeutics using Allogene Therapeutics' stock options and short interest. It helps to benchmark the overall future attitude of investors towards Allogene using crowd psychology based on the activity and movement of Allogene Therapeutics' stock price.
Allogene Therapeutics Short Interest
An investor who is long Allogene Therapeutics may also wish to track short interest. As short interest increases, investors should be becoming more worried about Allogene Therapeutics and may potentially protect profits, hedge Allogene Therapeutics with its derivative instruments, or be ready for some potential downside.
200 Day MA 1.2993 | Short Percent 0.0969 | Short Ratio 6.88 | Shares Short Prior Month 18 M | 50 Day MA 1.4428 |
Allogene Relative Strength Index
Allogene Therapeutics Hype to Price Pattern
Investor biases related to Allogene Therapeutics' public news can be used to forecast risks associated with an investment in Allogene. The trend in average sentiment can be used to explain how an investor holding Allogene can time the market purely based on public headlines and social activities around Allogene Therapeutics. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Some investors profit by finding stocks that are overvalued or undervalued based on market sentiment. The correlation of Allogene Therapeutics' market sentiment to its price can help taders to make decisions based on the overall investors consensus about Allogene Therapeutics.
Allogene Therapeutics Implied Volatility | 2.53 |
Allogene Therapeutics' implied volatility exposes the market's sentiment of Allogene Therapeutics stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Allogene Therapeutics' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Allogene Therapeutics stock will not fluctuate a lot when Allogene Therapeutics' options are near their expiration.
Allogene Therapeutics after-hype prediction price | USD 1.53 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Historical Fundamental Analysis of Allogene Therapeutics to cross-verify your projections. Prediction based on Rule 16 of the current Allogene contract
Based on the Rule 16, the options market is currently suggesting that Allogene Therapeutics will have an average daily up or down price movement of about 0.16% per day over the life of the 2026-03-20 option contract. With Allogene Therapeutics trading at USD 1.53, that is roughly USD 0.002419 . If you think that the market is fully incorporating Allogene Therapeutics' daily price movement you should consider acquiring Allogene Therapeutics options at the current volatility level of 2.53%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Open Interest Against 2026-03-20 Allogene Option Contracts
Although open interest is a measure utilized in the options markets, it could be used to forecast Allogene Therapeutics' spot prices because the number of available contracts in the market changes daily, and new contracts can be created or liquidated at will. Since open interest in Allogene Therapeutics' options reflects these daily shifts, investors could use the patterns of these changes to develop long and short-term trading strategies for Allogene Therapeutics stock based on available contracts left at the end of a trading day.
Please note that to derive more accurate forecasting about market movement from the current Allogene Therapeutics' open interest, investors have to compare it to Allogene Therapeutics' spot prices. As Ford's stock price increases, high open interest indicates that money is entering the market, and the market is strongly bullish. Conversely, if the price of Allogene Therapeutics is decreasing and there is high open interest, that is a sign that the bearish trend will continue, and investors may react by taking short positions in Allogene. So, decreasing or low open interest during a bull market indicates that investors are becoming uncertain of the depth of the bullish trend, and a reversal in sentiment will likely follow.
Allogene Therapeutics Additional Predictive Modules
Most predictive techniques to examine Allogene price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Allogene using various technical indicators. When you analyze Allogene charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Previous Accumulation Distribution | Accumulation Distribution | Trend |
| 1.2 M | 524166.0 |
| Check Allogene Therapeutics Volatility | Backtest Allogene Therapeutics | Information Ratio |
Allogene Therapeutics Trading Date Momentum
| On January 27 2026 Allogene Therapeutics was traded for 1.53 at the closing time. The top price for the day was 1.62 and the lowest listed price was 1.49 . The trading volume for the day was 6.5 M. The trading history from January 27, 2026 did not affect price variability. The overall trading delta against the current closing price is 1.31% . |
Accumulation distribution indicator can signal that a trend is either nearing completion, at a continuation, or is about to break-outs. The actual value of this indicator is of no significance. What is significant is the change in value of over time. The formula for A/D of a given trading day can be expressed as follow: ((Close - Low) - (High - Close)) / (High - Low) X Volume
| Compare Allogene Therapeutics to competition |
Other Forecasting Options for Allogene Therapeutics
For every potential investor in Allogene, whether a beginner or expert, Allogene Therapeutics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Allogene Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Allogene. Basic forecasting techniques help filter out the noise by identifying Allogene Therapeutics' price trends.Allogene Therapeutics Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Allogene Therapeutics stock to make a market-neutral strategy. Peer analysis of Allogene Therapeutics could also be used in its relative valuation, which is a method of valuing Allogene Therapeutics by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Allogene Therapeutics Market Strength Events
Market strength indicators help investors to evaluate how Allogene Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Allogene Therapeutics shares will generate the highest return on investment. By undertsting and applying Allogene Therapeutics stock market strength indicators, traders can identify Allogene Therapeutics entry and exit signals to maximize returns.
Allogene Therapeutics Risk Indicators
The analysis of Allogene Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Allogene Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting allogene stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 3.61 | |||
| Semi Deviation | 3.77 | |||
| Standard Deviation | 4.88 | |||
| Variance | 23.8 | |||
| Downside Variance | 20.68 | |||
| Semi Variance | 14.21 | |||
| Expected Short fall | (4.88) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Allogene Therapeutics
The number of cover stories for Allogene Therapeutics depends on current market conditions and Allogene Therapeutics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Allogene Therapeutics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Allogene Therapeutics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Allogene Therapeutics Short Properties
Allogene Therapeutics' future price predictability will typically decrease when Allogene Therapeutics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Allogene Therapeutics often depends not only on the future outlook of the potential Allogene Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Allogene Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 194.8 M | |
| Cash And Short Term Investments | 292.5 M |
Check out Historical Fundamental Analysis of Allogene Therapeutics to cross-verify your projections. To learn how to invest in Allogene Stock, please use our How to Invest in Allogene Therapeutics guide.You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Allogene Therapeutics. If investors know Allogene will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Allogene Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Allogene Therapeutics is measured differently than its book value, which is the value of Allogene that is recorded on the company's balance sheet. Investors also form their own opinion of Allogene Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Allogene Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Allogene Therapeutics' market value can be influenced by many factors that don't directly affect Allogene Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Allogene Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Allogene Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Allogene Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.